Eli Lilly and Novo Nordisk are involved in industry trends, including collaborating on AI initiatives and providing expert commentary via Reuters.
1 report, 1 independent
Updated May 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Novo Nordisk are involved in industry trends, including collaborating on AI initiatives and providing expert commentary via Reuters.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Tencent's healthcare division, led by Alex Ng, is noted as a major player in AI adoption trends alongside Eli Lilly and Novo Nordisk.Sub-event
Drug manufacturers Eli Lilly and Novo Nordisk are providing expert commentary on industry trends via Reuters.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Novo Nordisk
Danish pharmaceutical company
Related events
- Veeva Systems, Eli Lilly and Company, and Salesforce renewed a global partnership focused on AI adoption and migrating from legacy infrastructure.
- OpenAI and Anthropic announced a partnership to use Claude models in R&D, while Novo Nordisk and Eli Lilly intensify competition in the obesity drug market.
- Eli Lilly announced multiple new partnerships, including expanding Zepbound access with CVS Health, collaborating with Insilico Medicine, and investing in an AI lab with NVIDIA.